Bipolar Disorder: Latest Clinical Update

Slides:



Advertisements
Similar presentations
BIPOLAR DISORDERS Presented by:
Advertisements

Bipolar Disorder- Assessment B. Anthony Lindsey, MD Professor and Vice Chair UNC Department of Psychiatry.
Page of 11 The Pennsylvania Child Welfare Training Program308: Adult Psychopathology: Bipolar Disorder 1 The Pennsylvania Child Welfare Training Program.
Réunion Ambulatoires SAS,  Similarly, a statistically significant MADRS reduction over time was found (F=156.2, p 800 mg/day) and low (
2007. Statistics  2-4 new cases per 100,000/year  1 in 200 people will have an episode of hypomania  Peak age of onset yrs  May have had a previous.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Mood Disorders.
MOOD DISORDERS BIPOLAR DR. HASSAN SARSAK, PHD, OT.
Bipolar Disorders & Depressive Disorders DSM-5, 2013.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 33 Drugs for Bipolar Disorder.
Chapter 6 Bipolar and Related Disorders. Manic Episode Elated, expansive, or irritable mood and increased activity Plus at least three (four if the mood.
Mood Disorders: Bipolar
New treatment options for use in bipolar mania Dr C Verster Dept Psychiatry Uuniversity of Stellenbosch.
Chapter 13 Bipolar and Related Disorders Copyright © 2014, 2010, 2006 by Saunders, an imprint of Elsevier Inc.
Bipolar I Disorder Treatment. Therapeutic Goals Relief of immediate symptoms Improvement of patient’s well-being Elimination of stressors Combined pharmacotherapy.
Disseminating Findings of Drug Effectiveness Reports to Prescribers: The Case of Neurontin Tim Carey MD MPH Cathy Melvin PhD, MPH May, 2007 Funding source:
BIPOLAR DISORDER DR GIAN LIPPI CONSULTANT PSYCHIATRIST
Update in the Treatment of Depressive Disorders Renee Lamm MD ABPN, ABAM FAPA, FAAFP.
Bipolar Disorder. Hallmark of Bipolar Disorder Defined by manic symptoms – Elevated, expansive or irritable mood (or any combination of these moods) plus.
Treatment Resistant Pediatric BD Elham Shirazi M.D. Board of General Psychiatry Board of Child & Adolescent Psychiatry.
Long-Term Efficacy Data for Psychiatric Drugs Thomas Laughren, M.D. Director, Division of Psychiatry Products (HFD-130) PDAC Meeting (Oct 25, 2005)
MOOD DISORDERS 2 Dr Nesif J. Al-Hemiary MBChB - FICMS(Psych) International Associate of the RCPsych.(UK) International Associate of the RCPsych.(UK)
Types of Bipolar Disorder Bipolar I –More time in depressed state –Long periods of normality Bipolar II –Long episodes of depression, occasional hypomania.
Group members Gurpreet kaur Amritpal kaur Arshdeep singh uppal Sandeep kaur bhullar.
For MHD & Therapeutics is proud to present And Now Here Is The Host... Dr. Schilling.
BIPOLAR DISORDER, DR GIAN LIPPI CONSULTANT PSYCHIATRIST UNIVERSITY OF PRETORIA & WESKOPPIES HOSPITAL FORENSIC UNIT MANAGEMENT GUIDELINES.
Drugs for Bipolar Disorder. Bipolar Disorder  Formerly known as manic-depressive illness  Afflicts an estimated 3.7% of the adult population  Mainstays.
Bipolar Disorder. What is it? Definition: “previously known as manic depression - is a condition that affects your moods, which can swing from one extreme.
Bipolar II Disorder. Involves – Major Depressive Episodes and – Hypomanic Episodes Bipolar IIvsBipolar I (Hypomanic + MDD) (Manic + MDD)
PSY 270 Week 4 Individual Depression Paper Many people become depressed at some point in their lives, but when these feelings interfere with an individual’s.
Quetiapine Fumarate Quetiapine Fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar.
Bipolar Disorder- Assessment B
Module 3 Indications for Antipsychotics Bipolar Disorder
Presentation on Bipolar Disorder
S. Khaldi MD, C. Kornreich MD Phd Service de Psychiatrie.
Major Depressive Disorder: Latest Clinical Update
Lithium: Clinical Uses and Pharmacokinetics
Key Issues in Depression: Highlights From APA 2016
Bipolar I Depression Today: The Evolving Understanding of Bipolar Depression Neurobiology and the Relation to Diagnosis.
Introduction to bipolar disorder
Other drugs used in the treatment of bipolar disorder
Bipolar Depression Pharmacotherapy: Part 1
BIPOLAR DISORDER Insert name of instructor, title, and contact information.
افسردگی شناخت، ارزیابی، و پیشگیری در جمعیت دانشجویی
From the 2015 Conferences to the Clinic
افسردگی شناخت، ارزیابی، و پیشگیری در جمعیت دانشجویی
From Conference to the Clinic
Understanding the Many Faces of Pseudobulbar Affect
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
הרצאה יורם יובל המחלקה לפסיכולוגיה אוניברסיטת בר-אילן
Case Challenges in Chronic Migraine
The Mood Disorder Spectrum
Managing Depression in Bipolar I Disorder
Mood Disorders: Overview
Hyperhidrosis Is Burdensome!
Pseudobulbar Affect or Psychiatric Condition?
Antidepressants for Bipolar Depression: Answering Clinical Questions
When Is Intrathecal Drug Delivery Appropriate?
Scientific Update.
The Bipolar Disorder Concept From Kraepelin to DSM-V
The Challenges of Bipolar Disorders
Assessing the Burden of Hyperkalemia
When Is Intrathecal Drug Delivery Appropriate?
Assessing the Burden of Hyperkalemia
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Binge Eating Disorder.
Module 3 Indications for Antipsychotics Bipolar Disorder
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Diagnostic Criteria Migraine Without Aura
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Presentation transcript:

Bipolar Disorder: Latest Clinical Update

Introduction

Depression: Unipolar or Bipolar?

Bipolar Disorder Symptoms Are Chronic and Predominantly Depressive

Moving From a Categorical to a Dimensional Approach

Criteria for Depressive Episode With Mixed Features

Not Included in Mixed Specifier

Prevalence of Mixed Features in Bipolar Mood Episodes

Pediatric Bipolar Disorder

Treatment Trends in Bipolar Disorder

New FDA Bipolar Indications

8-Week Olanzapine + Fluoxetine in Pediatric Bipolar I Depression

Overview of Pediatric Acute Mania Studies: Efficacy

Recently Published Data

Comparative Evaluation of QUEtiapine + Lamotrigine Comparative Evaluation of QUEtiapine + Lamotrigine* vs Quetiapine in Bipolar Depression (CEQUEL)

Unapproved Bipolar Depression Tx: Benefits and Harms

24-Week Lithium + Adjunctive Personalized Treatment Vs Quetiapine + APT in Bipolar I Disorder and Bipolar II Disorder

New Data Presented at APA

Studies in Progress

Data Unlikely to Emerge

Conclusion

Florida Algorithm: Treatment of Acute Bipolar Depression

Florida Algorithm: Treatment of Acute Bipolar Depression (cont)

Abbreviations